Open-Label Surufatinib in European Patients With NET

Clinical trial NCT04579679 · TERMINATED

Trial details

NCT number: NCT04579679
Sponsor: Hutchmed
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumours Neuroendocrine Tumour of the Lung Small Intestinal NET

Start date: 2021-08-13
Primary completion: 2024-09-06
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.